C19H22FN3O3
359.4 g/mol
Wirkstoff (API)Gefahr
Enrofloxacin
Enrofloxacin
CAS93106-60-6
Kategorie
Wirkstoff (API)
Verbindungsklasse
Heterozyklus
Hauptverwendung
Pharma-Rohstoff
Enrofloxacin is a synthetic antibacterial compound used as an active pharmaceutical ingredient. It is characterized by a quinolone core structure with fluorine and piperazine substituents, contributing to its physicochemical properties such as moderate lipophilicity and limited aqueous solubility.
manufacturing of veterinary pharmaceutical formulationsraw material for solubility-enhanced salt forms
Geltungsbereich: Die Informationen auf dieser Seite betreffen die Identifizierung von Chemikalien sowie industrielle Liefer-, Forschungs- und Produktionskontexte. Sie stellen keine Heilversprechen, medizinische Beratung oder Anwendungshinweise für Arzneimittel dar.
Beschaffen oder liefern Sie diese Verbindung?
Inventar einstellen oder Kaufanfrage stellen
CAS 93106-60-6
Verwandte Verbindungen
StarkGleiche Grundstruktur
1-Cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid--hydrogen chloride (1/1)
CAS112732-17-9
active pharmaceutical ingredient
ÄhnlichStrukturähnlichÄhnlichkeit 0.73
1-cyclopropyl-6-fluoro-7-(4-nitrosopiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
CAS864443-44-7
antibacterial impurity standard
ReferenzGleiche Kategorie
Ciprofloxacin Hydrochloride Anhydrous
CAS93107-08-5
active pharmaceutical ingredient
ReferenzGleiche Kategorie
2-(4-methanesulfonylphenyl)oxirane
CAS93114-06-8
Active pharmaceutical ingredient intermediate
ReferenzGleiche Kategorie
TACALCITOL MONOHYDRATE
CAS93129-94-3
active pharmaceutical ingredient
ReferenzGleiche Kategorie
Levobetaxolol
CAS93221-48-8
beta-adrenergic receptor antagonist
Referenzsame scaffold
Desfluorociprofloxacin
CAS93107-11-0
pharmaceutical impurity reference standard
Referenzsame scaffold
Gatifloxacin sesquihydrate
CAS180200-66-2
fluoroquinolone antibiotic active pharmaceutical ingredient
Sicherheitsreferenz
Gefahr
H302Harmful if swallowed
H317May cause an allergic skin reaction
H334May cause allergy or asthma symptoms or breathing difficulties if inhaled
H361Suspected of damaging fertility or the unborn child
H372Causes damage to organs through prolonged or repeated exposure
H400Very toxic to aquatic life
H410Very toxic to aquatic life with long lasting effects
Identifikatoren
IUPAC-Name
1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxoquinoline-3-carboxylic acid
InChIKey
SPFYMRJSYKOXGV-UHFFFAOYSA-N
SMILES
CCN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)F
Synonyme (79)
- CFPQ
- ERFX
- Enrofloxacin (USAN/INN)
- Enrofloxacin (USP/INN)
- Enrofloxacin for system suitability, European Pharmacopoeia (EP)
- Enrofloxacin, European Pharmacopoeia (EP)
- Enrofloxacin, United States Pharmacopeia (USP)
- BAY VP 2674
- BAY Vp 2674;PD160788
- Baytril
- Baytril (TN)
- Baytril (veterinary)
- Baytril Soft Chewable Tablets
- ENROFLOXACIN 100
- ENROFLOXACIN [MART.]
- EnroMed
- EnroMed 100
- EnroPro 100
- EnroPro 22.7
- Enroflox
- Enroflox 100
- Enroflox Chewable Tablets
- Enroflox Injection for Dogs
- Enrofloxacin
- Enrofloxacin (Standard)
- Enrofloxacin CRS
- Enrofloxacin Flavored
- Enrofloxacin Flavored Tablets
- Enrofloxacin HCl
- Enrofloxacin base
- Enrofloxacin, >=98.0% (HPLC)
- Enrofloxacin, VETRANAL(TM)
- Enrofloxacine
- Enrofloxacine [French]
- Enrofloxacino
- Enrofloxacino [Spanish]
- Enrofloxacinum
- Enrofloxacinum [Latin]
- Enroquin
- Enroquin Flavored
- Enrosite
- Enrosite Flavored
- Enroxil
- Fluroxin
- Fluroxin Flavored
- Fluroxin for Dogs
- N-Ethylciprofloxacin
- Quellaxcin
- SolutionKits
- SolutionKits Enrofloxacin
- Tenotryl
- Zobuxa
- endrofloxicin